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Automated image analysis for
quantification of filamentous bacteria
Marlene Fredborg1,4*, Flemming S. Rosenvinge2, Erik Spillum3, Stine Kroghsbo3, Mikala Wang4 and Teis E. Sondergaard5
Abstract
Background: Antibiotics of the β-lactam group are able to alter the shape of the bacterial cell wall, e.g.
filamentation or a spheroplast formation. Early determination of antimicrobial susceptibility may be complicated by
filamentation of bacteria as this can be falsely interpreted as growth in systems relying on colorimetry or
turbidometry (such as Vitek-2, Phoenix, MicroScan WalkAway). The objective was to examine an automated image
analysis algorithm for quantification of filamentous bacteria using the 3D digital microscopy imaging system,
oCelloScope.
Results: Three E. coli strains displaying different resistant profiles and differences in filamentation kinetics were used
to study a novel image analysis algorithm to quantify length of bacteria and bacterial filamentation. A total of 12
β-lactam antibiotics or β-lactam–β-lactamase inhibitor combinations were analyzed for their ability to induce
filamentation. Filamentation peaked at approximately 120 min with an average cell length of 30 μm.
Conclusion: The automated image analysis algorithm showed a clear ability to rapidly detect and quantify
β-lactam-induced filamentation in E. coli. This rapid determination of β-lactam-mediated morphological alterations
may facilitate future development of fast and accurate AST systems, which in turn will enable early targeted
antimicrobial therapy. Therefore, rapid detection of β-lactam-mediated morphological changes may have important
clinical implications.
Keywords: Morphology, Antibiotic-induced filamentation, Digital microscopy, Time-lapse imaging, Cell elongation,
Escherichia coli
Background
Antibiotics of the β-lactam group are able to alter the
shape of the bacterial cell wall, e.g. inducing filamenta-
tion or a spherical shape of rod-shaped bacteria (Fig. 1)
[1–3]. Filamentation occurs when cell division is blocked
while growth continues leading to the formation of fila-
mentous bacteria with lengths of up to 50 times their
bacillary counterparts [4]. Filamentous morphology pro-
vides survival advantages: inhibits phagocytic uptake by
immune cells [5], promote survival within host tissue
[6, 7], and decrease susceptibility to certain antimicrobial
agents [4]. However, the transformation to grow in a fila-
mentous manner may not be enough to overcome a
certain environmental stress. In these cases, elongation of
the cell shape is followed by the presence of holes in the
cell wall, indicating irreversible damage, subsequently
resulting in exit of cytoplasmic material producing ghost
cells which will finally lyse and disappear [8]. Gram nega-
tive bacteria exposed to β-lactam antibiotics frequently
display a change towards a filamentatious morphology
which may allow for survival until the antibiotic is diluted
or becomes inactive [6]. Even though filamentation cannot
be directly correlated to antibiotic susceptibility or resist-
ance, it is pivotal knowledge in relation to early antimicro-
bial susceptibility testing (AST).
Beta-lactam antimicrobials are widely used to treat in-
fections; however, the alarming spread of β-lactam resist-
ance is increasingly reported worldwide and represents a
major health issue [9]. Among the most important
resistance mechanisms to penicillins and cephalosporins
in Enterobacteriaceae are extended spectrum β-lactamases
(ESBL) [10]. As infections caused by ESBL-producing
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pathogens may not be responsive to treatment with most
penicillins and cephalosporins, and as the genes encoding
this resistance mechanism are harbored on plasmids and
readily transferrable, their presence in a hospital setting
should be identified quickly to ensure appropriate anti-
microbial therapy [11, 12].
In a previous study, we demonstrated the oCelloScope
system as a fast and sensitive AST method [13]. The
oCelloScope system provides information on growth
kinetics based on advanced algorithms analyzing image
material. In this study, we present an image analysis algo-
rithm quantifying the length of bacteria and thus changes
in bacterial morphology. This is particularly important
when testing antibiotics such as penicillins, cephalospo-
rins, carbapenems, and monobactam. β-lactam-antibiotics
are known to induce morphological changes in bacteria
(e.g. filamentation or spheroplast formation) [8]. Rapid de-




To examine the antibiotic-induced morphological changes,
three E. coli strains were used displaying differences in
resistance profiles and filamentation kinetics: E. coli refer-
ence strain ATCC25922 (no resistance), a multi-drug re-
sistant ESBL-producing clinical isolate (aztreonam-R,
ceftazidime-R, piperacillin-R and ticarcillin-R), and an E.
coli from a positive blood culture (no resistance). Ethical
approval was not required for this study according to
Danish Law.
Growth conditions
The E. coli reference strain and the ESBL E. coli were
grown under atmospheric conditions at 37 °C in cation
adjusted Mueller-Hinton broth with TES (CAMHBT)
overnight. The blood culture E. coli strain was isolated
from a blood sample from a patient with bacteremia
which were collected in standard aerobe non-charcoal
BacT/ALERT FA blood culture bottles (bioMérieux,
Marcy l’Etoile, France), and handled according to the
manufacturer’s instructions. Blood culture bottles were
incubated in the BacT/ALERT 3D system (bioMérieux,
Marcy-l’Etoile, France) at Aarhus University hospital
(Aarhus, Denmark). The blood culture sample was pre-
pared by centrifugation at 200 × g for 5 min (Sigma 3–
18 k, 12171 rotor, Buch & Holm, Herlev, Denmark) to
remove human blood cells, followed by resuspension of
the bacterial pellet in CAMHBT.
Antibiotic-induced morphological changes
Bacterial suspensions were diluted to McFarland 0.5
based on OD600 measurements using a UV-3100 PC
Spectrophotometer (VWR, Herlev, Denmark) and sub-
sequently diluted in cation adjusted Mueller-Hinton
broth to a final bacterial cell suspension of approximately
1 × 105 bacteria/mL. Sensititre® NF plates (Thermo Scien-
tific, Roskilde, Denmark) were used to examine antibiotic-
induced morphological changes. The Sensititre NF plates
contain a total of 23 antibiotics of which 12 are β-lactam
antibiotics or β-lactam–β-lactamase inhibitor combi-
nations (ampicillin/sulbactam 2:1 ratio, aztreonam, carbe-
nicillin, cefepime, cefoperazone, cefotaxime, ceftazidime,
ceftriaxone, piperacillin, piperacillin/tazobactam constant
four, ticarcillin, and ticarcillin/clavulanic acid constant
two). Bacteria-antimicrobial suspensions were transferred
immediately from the Sensititre® plates to flat-bottomed
Nunc Edge 96-well plates, since the oCelloScope sys-
tem (Philips BioCell, Allerød, Denmark) cannot meas-
ure round bottom plates. No discrepancies were
associated with this step. All experiments on reference
strains and clinical isolates were carried out in biological
triplicates.
Data analysis
The oCelloScope is a digital time-lapse microscopy
technology that scans through a fluid sample generating
series of images as previously described in 2013 by
Fig. 1 Antibiotic-induced filamentation in E. coli by light microscopy.
Antibiotic-induced filamentation of E. coli ATCC259222 treated with
cefotaxime (8 mg/L) visualized in light microscopy with a 10x (a)
and a 100x (b) magnification
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Fredborg et al. [13]. The oCelloScope instrument was
placed inside an Innova 44 incubator (New Brunswick
Scientific) allowing precise temperature regulation. As a
result of the tilted imaging plane, the images recorded by
the oCelloScope system constitute a parallelepipedum that
forms the image stack. The projected z-stack image of a
single z-plane was generated by combining the tilted im-
ages. Each well was scanned repeatedly every 15 min for
12 h. Time-lapse experiments, digital analysis, and image
processing were conducted by a custom automation script
in MATLAB (MATLAB Version: 8.0.0.783 (R2012b), The
MathWorks Inc., Natick, MA, USA, 2000). Growth kinet-
ics was determined by image stack processing based on
contrast based Segmentation and Extraction of Surface
Area (SESA). The Segmentation Extracted Average
Length (SEAL) algorithm was designed to detect fila-
mentation of rod shaped bacteria. SEAL determines
the mean bacterial length and use contrast-based seg-
mentation followed by morphological filtering on a
projected z-stack image to measure the major axis
length of each individual object. SEAL is limited
when cells are overlapping and may lead to inaccurate
determination of bacterial length at high cell concen-
trations or if bacterial filaments are crossing each
other. Objects that spans the edge of the field of view
are not included. GraphPad Prism version 6.00 for
Windows, (GraphPad Software, San Diego, California,
USA) was used for data analysis and graphing.
Results and discussion
Determination of bacterial length
Figure 1 shows antibiotic-induced filamentation in E. coli
ATCC259222 by light microscopy. To examine the abil-
ity of the oCelloScope system to rapidly determine fila-
mentation of E. coli, three E. coli strains were inoculated
with a total of 12 β-lactam antibiotics or β-lactam–β-lac-
tamase inhibitor combinations. Phenotypic antimicrobial
susceptibility by the oCelloScope has previously been
determined using the contrast based segmentation and
extraction of surface area (SESA) algorithm [13]. How-
ever, when focusing on early detection of antimicrobial
susceptibility within the first 60–120 min, antibiotic-
induced bacterial filamentation may lead to deceptive
interpretation of results. The E. coli reference strain was
grown with and without the β-lactam antibiotic, cefotax-
ime. As seen in Fig. 2, filamentation affects growth kin-
etic measurements, because the algorithm is unable to
distinguish between normal growth and filamentation,
since both growth patterns resulted in an increased
image area covered by bacteria – the value quantified by
the algorithm. To be able to distinguish between these
two growth patterns is particularly important when
focusing on early determination of antimicrobial suscep-
tibility, since this is complicated by filamentous bacteria
as their elongated cell length may falsely be interpreted
as normal growth. Consequently, we developed an algo-
rithm to determine mean bacterial length of rod shaped
Fig. 2 Effect of piperacillin on growth and length of E. coli obtained by the oCelloScope system. a Quantification of bacterial growth kinetics and
filamentation was determined for untreated (stippled lines) and cefotaxime-treated (solid lines) E. coli by two different algorithms: Growth kinetics
(blue graphs) was measured based on segmentation and extraction of surface area, and bacterial length (green graphs) based on segmentation
extracted average length. Images of E. coli morphology treated with 8 mg/L of cefotaxime were obtained by the oCelloScope system at time
b 60 min, c 120 min, d 180 min, and at e 240 min
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bacteria based on segmentation extraction of average
length (SEAL). In addition to measurements of growth
kinetics, the E. coli reference strain was analyzed with
the novel algorithm to determine bacterial elongation
(Fig. 2a and Additional file 1: Movie S1). Morphological
changes induced in the E. coli reference strain by cefo-
taxime were clearly visualized by the oCelloScope system
after 30, 90, and 150 min of inoculation (Fig. 2b–d) and
rapidly detected by the length quantifying algorithm
(Fig. 2a, green stippled and full lines). The obtained
results showed that treatment with cefotaxime initially
increased the length of the E. coli reference strain dras-
tically by inducing filamentation followed by lysis of the
bacterial cells. Antibiotic-induced changes in E. coli
morphology from elongation of cells to the production
of ghost cells are a well-known phenomenon [14, 15].
Filamentation peaked at approximately 90 min with an
average cell length of approximately 30 μm, (Fig. 2a, c).
Table 1 Effect of 12 β-lactam antibiotics or β-lactam–β-lactamase inhibitor combinations on antibiotic-induced filamentation (AIF) of
three E. coli strains. The antibiotic concentrations of which filamentation is induced are given, if not detected for all concentrations
(All) or if no filamentation is detected (N.D.; not detected). In addition, MIC values and the time required to detect them are included
(time-to-result in minutes; TTR, (mean ± SE))
E. coli ATCC 25922 ESBL-producing E. coli Blood culture E. coli
β-lactam antibiotics or β-lactam–
β-lactamase inhibitor combinations
AIF MIC TTR AIF MIC TTR AIF MIC TTR
conc. (min) conc. (min) conc. (min)
ampicillin/sulbactam 2:1 ratio 2/1–8/4 4/2 97 ± 3.33 16/8 16/8 100 ± 0 2/1–8/4 ≤2/1 113 ± 6.67
aztreonam All ≤ 2 115 ± 5 N.D. >16 65 ± 5 All ≤ 2 103 ± 1.67
carbenicillin 32–128 ≤ 32 102 ± 1.67 N.D. 256 55 ± 5 All ≤ 32 60 ± 0
cefepime 2–4 ≤ 2 103 ± 1.67 All 4 117 ± 3.33 2–4 ≤ 2 132 ± 6.01
cefoperazone All ≤ 4 117 ± 3.33 All 8 133 ± 6.67 All ≤ 4 155 ± 5
cefotaxime 4–8 ≤ 4 102 ± 1.67 All ≤ 4 103 ± 1.67 4–8 ≤ 4 93 ± 3.33
ceftazidime All ≤ 1 133 ± 6.67 N.D. >16 62 ± 1.67 All ≤ 1 117 ± 3.33
ceftriaxone 4–8 ≤ 4 93 ± 3.33 All ≤4 115 ± 5 4–8 ≤ 4 97 ± 3.33
piperacillin All ≤ 8 103 ± 1.67 N.D. >64 55 ± 5 All ≤ 8 163 ± 1.67
piperacillin/tazobactam constant four All ≤ 8/4 113 ± 6.67 F ≤8/4 162 ± 1.67 All ≤ 8/4 115 ± 5
ticarcillin All ≤ 8 123 ± 3.33 N.D. >64 65 ± 5 All ≤ 8 100 ± 0
ticarcillin/clavulanic acid constant two 16/2–32/2 8/2 138 ± 1.67 N.D. 128/2 163 ± 1.67 16/2–64/2 ≤ 16/2 102 ± 1.67
Fig. 3 Early detection of antibiotic-induced filamentation of ESBL-producing E. coli by β-lactam–β-lactamase inhibitor combinations. Growth
kinetics and mean bacterial length of E. coli treated with piperacillin/tazobactam (32/4 mg/L) (a–b) or ticarcillin/clavulanic acid (32/2 mg/L) (c–d).
The piperacillin/tazobactam-induced filamentation (increased length >5 μm) can be determined within 30 min, while the absence of ticarcillin/
clavulanic acid-induced filamentation can be determined within 40 min
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In concordance, β-lactam-induced elongation of cefazo-
lin treated E. coli examined with dielectrophoresis dem-
onstrated peaks in bacterial cell length after 120 min of
incubation [16]. Examination of filament formation in
both antibiotic resistant and sensitive E. coli showed that
the filament formation was an initial response to cefo-
taxime occurring after 2 h of inoculation [17].
Even though 8 mg/L cefotaxime is the CLSI break-
point concentration for ESBL-producing E. coli strains
[18] and not for the E. coli reference control strain, it
clearly demonstrates the point that if susceptibility of
this strain was to be determined after 90 min based on
the growth determining algorithm or systems relying on
colorimetry or turbidometry, it would lead to the
classification of this strain to be resistant to cefotaxime at
the concentration of 8 mg/L. The ability of the length
quantifying algorithm to differ between bacterial growth
and filamentation, and in this situation clearly state that
the latter is the case, enables correction of the falsely
interpretation of filamentation as growth. Since fila-
mentation is not directly correlated with antibiotic sus-
ceptibility or resistance, this cannot be determined at
this time point, which is pivotal knowledge in relation
to early AST.
Early detection of β-lactam antibiotic-induced
filamentation
A total of 12 β-lactam antibiotics or β-lactam–β-lacta-
mase inhibitor combinations (ampicillin/sulbactam 2:1
ratio, aztreonam, carbenicillin, cefepime, cefoperazone,
cefotaxime, ceftazidime, ceftriaxone, piperacillin, pipera-
cillin/tazobactam constant four, ticarcillin, and ticarcil-
lin/clavulanic acid constant two) were analyzed for their
ability to induce filamentation in the three included
Fig. 4 Effects of β-lactam–β-lactamase inhibitor combinations on E. coli growth kinetic. Reference strain E. coli, ESBL-producing E. coli, and a blood
culture E. coli was treated with 4 different concentrations of either piperacillin alone (a–c) or with supplementation of tazobactam (d–f) as well as
ticarcillin alone (g–i) or with supplementation of clavulanic acid (j–l). Growth kinetics were measured repeatedly every 15 min for 10 h
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E. coli strains (Table 1). These 12 β-lactam antibiotics
included four (ceftazidime, aztreonam, cefotaxime, and
ceftriaxone) of the five antibiotics recommended by CLSI
to constitute the ESBL initial screening test [18].
The screening demonstrated significant variations in
antibiotic-induced filamentation depending both of the
specific antibiotic and the antibiotic concentration (from
sub-minimum inhibitory concentration (MIC) and up
to 5 ×MIC). The use of the two algorithms (SEAL
and SESA) in combination facilitates early detection
of antibiotic-induced filamentation. Piperacillin/tazobac-
tam-induced filamentation (increased length >5 μm) can
be determined within 30 min, while the absence of ticar-
cillin/clavulanic acid-induced filamentation can be deter-
mined within 40 min (Fig. 3). Based on the absence of
filamentation and the presence of normal growth when
testing β-lactam–β-lactamase inhibitor combinations,
the oCelloScope system holds the potential of rapidly
determining the phenotype of β-lactamase producing
bacteria – e.g. ESBL-producers by combining cephalo-
sporins with β-lactamase inhibitors. Early determination
of antimicrobial susceptibility is complicated in the case of
filamentous bacteria such as E. coli as their elongated cell
length may falsely be interpreted as growth in systems
based on colorimetry or turbidometry (such as Vitek-2,
Phoenix, MicroScan WalkAway). Consequently, the deter-
mination of β-lactam-mediated morphological alterations
facilitates early appropriate targeted antibiotic therapy.
The emerging interest in detection of β-lactam antibiotic
induced morphological effects is seen by the recent devel-
opment of techniques aimed at rapid detection of this
phenomenon [16, 19–21].
The target for β-lactam antibiotics is cell wall synthe-
sizing enzymes that have sensitivity towards penicillin,
Fig. 5 Effects of β-lactam–β-lactamase inhibitor combinations on bacterial length of E. coli. Reference strain E. coli, ESBL-producing E. coli, and a
blood culture E. coli was treated with 4 different concentrations of either piperacillin alone (a–c) or with supplementation of tazobactam (d–f) as
well as ticarcillin alone (g–i) or with supplementation of clavulanic acid (j–l). Bacterial length was measured repeatedly every 15 min for 10 h
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named penicillin-binding proteins (PBPs). The intrin-
sic β-lactamase resistance associated with PBP is an
important mechanism in clinical isolates [22]. In E.
coli, piperacillin exhibits high selective affinity to-
wards PBP-3 and PBP2, as well as moderate binding to
PBP1b [23–25]. Each PBP serves an essential role in bac-
terial cell life: PBP1a and 1b are responsible for cell elong-
ation, PBP2 for cell shape, and PBP3 for cell division [25].
Inhibition of the latter results in cell filamentation, which
is in concordance with the oCelloScope system detecting
increased bacterial cell length for the E. coli reference
strain and the blood culture E. coli, but not for the
ESBL-producing E. coli when inoculated with 8–64 mg/
L of piperacillin (Figs. 4 and 5a–c). Likewise, bacterial
cell filamentation was detected by the oCelloScope sys-
tem for the E. coli reference strain and blood culture
isolate when inoculated with ticarcillin (8–64 mg/L),
but not for the ESBL-producing E. coli (Figs. 4 and 5g–i).
Ticarcillin preferentially binds to PBP-3 thereby inhi-
biting the last step of peptidoglycan synthesis in the
septum formation leading to filamentation [8]. When
analyzing the β-lactam–β-lactamase inhibitor combin-
ation, ticarcillin/clavulanic acid, increased bacterial
cell length was observed for the E. coli reference
strain and blood culture isolate in a dose–response
manner in which the longest cell length was observed
for the lowest concentration of the β-lactam antibiotic
(Figs. 4 and 5j–l). No filamentation was observed for
the ESBL-producing E. coli. Hence, this finding to-
gether with the growth detected by the SESA algo-
rithm demonstrated that the combination therapy had
no effect on the ESBL-producing E. coli (Figs. 4–5h
and k).
Conclusion
We presented an automated image-based algorithm
which enables determination of antibiotic-induced
filamentation. The method facilitates high-throughput
screening of bacterial filamentation and thus has the
potential to enhance antimicrobial susceptibility test-
ing by providing this important knowledge to elimin-
ate false susceptibility results in automated systems.
The ability to determine the absence of filamentation
and thereby the growth and resistance to an antibiotic
enables the oCelloScope to be used as an early pre-
dictor of resistant bacteria. As for fast and accurate
elucidation of filamentation and antibiotic resistance
of clinical samples, it is recommended that the bac-
teria are in their exponential growth phase prior to
addition of antimicrobials, and that the same growth
media is used in the preparation and screening of the
bacteria. Optimization of growth media to different
bacterial strains and to the fastest rate of filamentation
is endorsed.
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Additional file 1: Piperacillin-induced filamentation in E. coli. The
time-lapse movies show E. coli treated with piperacillin (PIP, 64 mg/L)
and without (Positive control), respectively; as well as graphs showing
growth and average length of the bacteria. (MOV 4671 kb)
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